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Summary.-The effects of rat tumours of various macrophage contents on the
syngeneic host's ability to produce either: (1) an inflammatory exudate in response to
intraperitoneal oyster glycogen -or (2) a cutaneous delayed hypersensitivity (DHS)
response to PPD or SRBC after appropriate sensitization, were studied as a function
of tumour growth.
Both these reactions were found to be markedly decreased as the tumours grew.
The suppression was greatest in animals bearing tumours of high macrophage
content. The suppression of the DHS response could be reversed by a local injection
of normal peritoneal macrophages with the eliciting antigen, and lymphocytes from
tumour bearing animals exhibiting poor DHS responses were able to adoptively
transfer DHS reactivity to normal unsensitized recipients. The monocyte infiltra-
tion in response to oyster glycogen was also decreased, and these data indicate a
monocyte, rather than a lymphocyte defect in the tumour induced " anergy " in this
system.
PATIENTS with carcinomata and lym-
phomata are often unable to express
delayed cutaneous hypersensitivity reac-
tions to antigens with which they have
been previously sensitized (Southam, 1968)
or to produce normal cellular exudates in
response to skin abrasions (Dizon and
Southam, 1963). These failures to mount
an inflammatory response are often taken
to imply a state of immunological anergy,
yet there are frequently no other symp-
toms indicative of immune deficiency; e.g.
antibody levels in response even to the
same antigens which fail to produce DHS
reactions arefrequentlynormal (Ashikawa,
Motoya and Sekiguchi, 1967). We set out
to test whether these examples of cellular
unresponsiveness, which are also seen in
tumour bearing animals, could be due to a
deficiency of cells of the monocyte-
macrophage series, since such cells are
needed to react with sensitized lympho-
cytes to give a delayed cutaneous reaction
to antigen, and also constitute the major
cell type in inflammatory exudates after
the first 24-48 h.
Evans (1972), using various criteria
such as adhesion to glass or plastic in the
presence of trypsin, lysis by specific anti-
macrophage serum and phagocytic ability,
showed that the number ofmacrophages in
rodent tumours, including the sarcomata
studied here, is often higher than con-
ventional histopathological methods might
suggest. In a series of primary and
transplanted tumours in rats and mice, the
macrophage content ranged from 4 to 56%
ofthe total cell population. Tumour cells
freed of macrophages and transplanted
into syngeneic recipients regained the
macrophage content typicalofthattumour
line, demonstrating the host origin ofthese
cells. It is probable that the precursors of
tumour macrophages are the blood mono-
cytes, since these cells provide the macro-
phages seen in inflammatory exudates
(Spector, Walters and Willoughby, 1965),
and delayed hypersensitivity reactions
(Volkman and Collins, 1968), and we
therefore intended to test the hypothesis
that growing tumours may interfere with
the expression of these responses, bySEQUESTRATION OF MACROPHAGES IN GROWING TUMOURS
competing for available blood mono-
cytes.
In the experiments to be described, the
effects of tumours of various macrophage
contents on (a) the number of macro-
phages appearing in inflammatory peri-
toneal exudates and (b) the extent of
cutaneous delayed hypersensitivity reac-
tions were studied as a function oftumour
growth.
MATERIALS AND METHODS
Two chemically induced sarcomata, desig-
nated MC-3 and HSBPA, were transplanted
into syngeneic Hooded rats for comparison
with normal controls. Their macrophage
contents were approximately 8% and 55%
respectively, which remained relatively con-
stant throughout the period of tumour
growth studied, as previously reported by
Evans (1972).
Induction of inflammatory exudate.-
Exudates were induced by the intraperitoneal
administration of 4 mg of oyster glycogen in
10 ml sterile saline at various times during
tumour growth, and in normal control rats.
The total number of monocytes and macro-
phages in the peritoneal cavity was deter-
mined 4 days later.
Induction of cutaneous delayed hyper-
sensitivity.-Increase of foot thickness after
intradermal injection of antigen is an estab-
lished method of quantitating the extent of
cutaneous DHS in rodents (Collins and
Mackaness, 1970), and we have confirmed
that the swelling at 24 h is associated with an
intense infiltrate of mononuclear cells.
Two antigens wereused: SRBC and B.C.G.
With the former, the rats were immunized
once with SRBC in Freund's complete
adjuvant and challenged with SRBC alone
intradermally on the upper surface of a hind
foot, the other foot being injected with saline
as a control. With B.C.G., however, 2 im-
munizations were necessary, given at an
interval of 7 days, and the eliciting antigen
used was PPD. The differences in diameters
of test and control feet were generally
expressed as a percentage, to diminish the
variation due to animals in different experi-
ments not always being exactly the same size.
For both systems, maximum foot swelling
was obtained if the eliciting antigen was ad-
ministered 13 days after the last immuniza-
tion and the foot measurements made 24 h
later at 14 days (Fig. 1). The swelling was
produced only in response to the specific
eliciting antigen and not by others, and no
reactions were seen when antigenic material
was injected into unsensitized rats.
To determine the effect of growing
tumours onthisreaction, ratswereimmunized
with either B.C.G. or SRBC as described, and
the tumours were inoculated subcutaneously
in each flank at different times with respect to
immunization, in order to give tumours of
different sizes atthetime ofantigen challenge.
RESULTS
1. Effect of growing tumours on the intra-
peritoneal inflammatory response
Figure 2 shows that as the tumours
grow, the number of monocytes which
enter the peritoneal cavity in response to
stimulation falls, but this occurs more
rapidly with the tumour of high macro-
phage content, the HSBPA sarcoma, than
with the tumour of low macrophage
content, the MC-3 sarcoma. When the
HSBPA tumour was approximately 20 g
in weight, there was no detectable response
to oyster glycogen, whereas in rats bearing
MC-3 tumours of the same weight the
response to the oyster glycogen was sup-
pressed by less than 50%. The presence
of the tumour did not significantly lower
the macrophage count in the unstimulated
cavity, although the numbers did drop
slightly when the tumours were verylarge;
this is not surprising, since the peritoneal
macrophages are known to be long-lived,
with a turnover time of about 40 days
(Van Furth and Cohn, 1968), and a lack of
recruitment in the later stages of tumour
growth would not greatly affect their
numbers.
These results are consistent with the
hypothesis that the tumours, possibly by
competition, interfere with the recruit-
ment of blood-borne monocytes to other
sites of inflammation. In experiments
with guinea-pigs contradictory results
have been reported for the effects of
growing tumours on peritoneal exudates
(Bernstein, Zbar and Rapp, 1972). Our
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Fi(c. 1. Delayedl hypersensitivity response to B.C.G. or SRBC in normal Hooded rats. 0, Day 0,
0 1 ml of SRBC in Freund's complete adjuvant (1: 1 25% SRBC in saline + CFA) i.p. and 4 sites
i.d. Eliciting dose to foot (id), 0 1 ml 75 .% SRBC in saline. A, Day 7 and Day 0. B.C.G.
(Glaxo). 300 yig in 01 ml saline 1 site i.d. Eliciting dose to foot (i.d.) 50 ,ug PPD in 01 ml saline.
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Fia. 2.-Kinetics of intraperitoneal oyster glycogen response in HSBPA an(d MC-3 tumouir bearing
rats. A, Normal control iats; *, AIC-3 tumour bearing rats; 0, HSBPA tumour bearing rats;
-c-a-v-iti unstimulate(d peritoneal cavitie-; , oyster glycogen (4 mg) stimulated peritonieal cavities.
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results indicate that these discrepancies
may be due to differences in the macro-
phage content of the tumours used.
2. Effect of growing tumours on cutaneous
delayed hypersensitivity
Figure 3 shows that the HSBPA
sarcoma (containing 55% macrophages)
ablates the expression of DHS to SRBC
much earlier (i.e. when much smaller) than
the MC-3 tumour which contains only
about 8co macrophages. In a small
series of experiments, different sized
inocula ofHSBPA tumour cells were given
which produced different sized tumours at
14 days. In B.C.G. immunized animals,
the degree of DHS expressed was again
inversely related to the size of the tumour
at challenge, showing that it is this
parameter rather than the length of time
the tumour has been growing which is
important in determining the degree of
reactivity of the host.
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The table illustrates that growing
HSBPA or MC-3 tumours have a similar
effect on B.C.G. induced DHS (here
expressedasabsoluteincreasesindiameter)
and also that within 7 days of surgical
removal of the tumours the rats had
regained their ability to mount a DHS to
the antigen to which they had been sensi-
tized, unless there was evidence ofresidual
tumour or metastases at the time of
challenge. In these occasional cases, the
rats appeared not to recover their DHS
response as well as those without demon-
strable tumour. This experiment also
provides circumstantial evidence that it is
the expression of DHS which is affected in
the tumour bearing animal rather than the
induction phases, since in rats showing
good DHS reactions after tumour excision,
the immunization procedures were carried
out at times when the animals bore large
tumours.
Further evidence that there is a direct
uays arrer s/c tumour inoculation
FiG. 3.-Kinetics of suppression of delayed hypersensitivity response to SRBC in HSBPA and MC-3
tumour bearing rats. 0, MC-3 tumour bearing rats; 0, HSBPA tumour bearing rats. Interval
between sensitization and challenge 13 days, skin reactions measured at 24 h.
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TABLE.-Delayed Cutaneous Hypersensitivity Responses to B.C.G. in Rats Bearing
HSBPA or MC-3 Sarcomata, and the Effect ofTumour Excision
Increase in foot thickness 24 hours after PPD (mm)
Days after tumour inoculation
A Days after tumour excision
Tumour inoculated 7 14 21 1 3 7
None (controls) 1-18±0-20 0*91±0*16 0-98±0-10 0-84±0-10 1b06±0-21 1-00±0-19
MC-3 (low macrophage 0 95±0 22 0 61±0*11 0*41±0 06 NT NT 0*90+0*26
content) *0.52+0-14
HSBPA (high 0-72+0-13 0-32+0-09 0 05+0 03 0-46+0-11 0-50+0-16 0-93+0-20
macrophage content)
* Animals with recurrent tumour or metastases.
NT = Not tested.
The diameters of control, saline injected, feet of rats used in this experiment were 3-2-3-3 mm.
relationship between the number ofmacro-
phages sequestered in a tumour and the
extent to which cutaneous DHS is sup-
pressed is shown in a comparison of the
effects of 9 different tumours, 2 primary
benzpyrene induced and others chemically
induced and transplanted. In this series,
the DHS reaction was tested in B.C.G.
sensitized rats when all tumours weighed
15-20 g. Figure 4 shows a direct cor-
relation between the macrophage content
ofthe tumours and the suppression offoot
swelling, after intradermal injection of
PPD.
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FIG. 4. Degree ofsuppression of delayed hypersensitivity reaction to B.C.G. in rats bearing tumours
of different macrophage contents. 0, Primary-benzpyrene induced tumours; 0, transplanted
methylcholanthrene induced tumours; A, transplanted benzpyrene induced tumours. Interval
between sensitization and challenge 13 days, skin reactions measured at 24 h.*~~~~~
46
r-
8( .SEQUESTRATION OF MACROPHAGES IN GROWING TUMOURS
Failure to detect a lymnphocyte defect
Lubaroff and Waksman (1968) showed
that the capacity to develop a DHS
reaction to PPD could be adoptively
transferred to non-immune rats with
intravenously administered lymphoid cells
from B.C.G. immunized rats. Figure 5
shows that, following sensitization with
B.C.G., lymph node cells from both
normal rats (i.e. rats giving a DHS
reaction with PPD), and from tumour
bearing rats (i.e. rats exhibiting various
degrees of DHS suppression) are able to
transfer reactivity to approximately the
same extent. This experiment confirms
an earlier study in which it had been
observed that in tumour bearing rats the
lymphoid response to antigens unrelated
to the tumour was normal; it is only the
response to tumour specific antigen which
is paralysed by the growing tumour, pre-
suimably due to excess antigen either free
or complexed with antibody (Alexander
et al., 1967).
Restoration of DHS by peritoneal cells
Volkman and Collins (1971) found that
the abrogation of a DHS reaction as
measured by foot swelling which followed
a whole-body dose of x-rays could be
reversed if the eliciting antigen was
injected together with macrophages from
non-sensitized animals. The depression
of DHS caused by the presence of a
growing tumour can be similarly reversed
(see Fig. 6) by peritoneal exudate cells
obtained 4 days after stimulation with
oyster glycogen, 65-75% of these cells
being monocytes and macrophages. That
the restorative effect cannot be attributed
to the 10-12% lymphocytes which are also
present is indicated by the inability of
thoracic duct lymphocytes to restore the
DHS response. It is also unlikely that the
expression of DHS
in cell donors
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FiG. 5. Transfer of delayed hypersensitivity with lymph node cells from normal or tumour bearing
rats sensitized to B.C.G. Each point represents 1 rat, and the horizontal bar is the mean for the
group. Lymph nodes were taken 8 days after sensitization; 2-4 x 108 cells injected i.v. into recipi-
ent rats, which were challenged with 50 ,ug PPD 1 day later. Skin reactions measured at 24 h.
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Fie;. 6. Restorative effect of various cell types on the impaired delaye<l hypersensitivity response to
B.C.G. in HSBPA tumour bearing rats. Each point represents 1 rat, an(l the horizontal bar is the
mean for the group. Challenge dose of PPD 50 ,ug, + 107 peritoneal exudate cells or lymphocytes.
effectiveness of the peritoneal cells is due
to the small number of polymorphs
present, since no mediatory properties in
the DHS response have been attributed to
these cells (V'olkman and Collins, 1971).
DISCUSSION
The view that the expression of a DHS
requires both immune lymphoid cells and
monocytes (macrophages) which initially
carry no specificity is experimentally well
supported. A defect in the expression of
cutaneous delayed hypersensitivity can
therefore arise from either (or both) the
inability to produce at the renaction site
sensitized lymphoid cells or sufficient
numbers of macrophages. These experi-
ments have demonstrated that both
primary and transplanted sarcomata may
attract large numbers of monocytes and
cause a defect of cutaneous DHS which
can be corrected by the local injection of
macrophages with the eliciting antigen.
The magnitude of the DHS impairment is
not determined by the size of tumours or
by the length of time they have been
growing in the host, but by the total
number of macrophages present in the
tumours. While for the tumours studied
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there is no evidence of a defect at the
lymphocyte level, this may not always be
the case andthe DHS lesion in some cancer
patients, particularly those with neo-
plasia involving lymphoid organs, may be
due at least partly to lymphocyte un-
reactivity. However, the concurrent in-
ability for monocytes to become mobilized
to sites of inflammation shown in our
experiments, and also reported in other
tumour bearing animals (Bernstein et al.,
1971) and in cancer patients (Dizon and
Southam, 1963) draws attention to the
fact that many so-called states of
" anergy " may not be failures of specific
immunological recognition or reactivity,
but are due to an unavailability of mono-
cytes to fulfil the expression of these
phenomena.
This investigation has been supported
by grants from the Cancer Research
Campaign and thc Medical Research
Council.
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